Health-Related Quality of Life (HRQoL) with Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC) with Brain, Liver, Adrenal, or Bone Metastases in the Phase II VISION Trial